Internal Medicine, Hematology & Oncology · Sacramento, CA
NPI
1699748707
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1020 29th St, Suite 680
Sacramento, CA, 95816
Phone (916) 453-3313
Medicare paid, 2024
$282K
2,193 services
Medicare patients, 2024
559
Average age 75
Drug cost, 2024
$12.1M
2,173 prescriptions
Company payments, 2025
$20.04
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P Carroll was code 99215 (office e&m - established), 915 times for 203 patients. In total Michael P Carroll billed 2,193 services in 18 codes, and Medicare paid $282K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 915 | 203 | $142.45 | $130K |
| 99233 Hospital E&M - Subsequent | Facility | 449 | 76 | $95.60 | $43K |
| 99214 Office E&M - Established | Office | 283 | 189 | $92.46 | $26K |
| 99291 Critical Care E&M | Facility | 246 | 32 | $170.42 | $42K |
| 99204 Office E&M - New | Office | 111 | 111 | $125.68 | $14K |
| 99223 Hospital E&M - Initial | Facility | 37 | 29 | $140.68 | $5,205 |
| 99239 Hospital Discharge Management | Facility | 27 | 19 | $93.88 | $2,535 |
| 38222 Other Organ Systems | Office | 22 | 18 | $152.73 | $3,360 |
| 38222 Other Organ Systems | Facility | 19 | 18 | $60.95 | $1,158 |
| 99205 Office E&M - New | Office | 18 | 18 | $183.55 | $3,304 |
By year: 2022 $302K for 2,309 services; 2023 $311K for 2,543 services; 2024 $282K for 2,193 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael P Carroll prescribed most often to Medicare patients was Acyclovir, with 219 prescriptions and refills. In total Michael P Carroll wrote 2,173 Medicare prescriptions that cost $12.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 219 | 484 | 64 | $5,614 |
| Imbruvica Ibrutinib | 160 | 162 | 17 | $2.7M |
| Lenalidomide Generic | 148 | 148 | 17 | $2.3M |
| Dexamethasone Generic | 94 | 153 | 29 | $1,856 |
| Hydroxyurea Generic | 83 | 196 | 25 | $3,301 |
| Jakafi Ruxolitinib Phosphate | 78 | 78 | Under 11 | $1.3M |
| Oxycodone Hcl Generic | 74 | 74 | Under 11 | $1,834 |
| Famotidine Generic | 61 | 158 | 21 | $1,178 |
| Pomalyst Pomalidomide | 57 | 57 | Under 11 | $1.2M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 114 | 20 | $552 |
| Ciprofloxacin Hcl Generic | 49 | 55 | 28 | $1,305 |
| Tasigna Nilotinib Hcl | 47 | 47 | Under 11 | $972K |
| Cyclosporine Modified Cyclosporine, Modified | 45 | 55 | Under 11 | $5,122 |
| Potassium Chloride Generic | 44 | 110 | 14 | $1,165 |
| Revlimid Lenalidomide | 39 | 39 | 16 | $741K |
Brand drugs: - claims; generic drugs: 1,445 claims; opioid claims: 162.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael P Carroll $20.04 ($20.04 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $20.04.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $20.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.